WinterGreen Research, a research organization that conducts studies globally, released a study that looked at the market shares, strategy and forecast globally from 2015 to 2021 of 2D X-ray equipment.
Here are five key points:
1. Technological advances, government investment, aging population, and disease prevalence increase all indicate growth in the 2D X-Ray market. X-Ray technology is less expensive and consequents in as much as 400 times less dosage than CT scans.
2. MRI and CT scans place more financial strains on hospitals already tight on budgets, while X-Ray technology offers workflow improvements and gives physicians clearer images.
3. Insurers are beginning to cover less MRI and CT scans because studies have shown that the tests are overused. Therefore, investment in X-Ray equipment will become more profitable as healthcare providers start to feel the financial strains of MRI and CT equipment.
4. The growth segments in the market include mammography and interventional radiology.
5. The market was $5 billion in 2014 and WinterGreen predicts it will reach $16.9 billion by 2021. Growth correlates with an increasing aging population, as areas like China build improved healthcare facilities and as improved 2D X-Ray diagnostics and therapeutics equipment increase demand.